HighMark Wealth Management’s Protolabs PRLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$28.1K Hold
345
0.01% 221
2026
Q1
$19.7K Hold
345
0.01% 225
2025
Q4
$17.5K Hold
345
0.01% 256
2025
Q3
$17.3K Hold
345
0.01% 251
2025
Q2
$13.8K Hold
345
0.01% 265
2025
Q1
$12.1K Hold
345
0.01% 256
2024
Q4
$13.5K Hold
345
0.01% 248
2024
Q3
$10.1K Sell
345
-9,600
-97% -$293K 0.01% 299
2024
Q2
$307K Hold
9,945
0.18% 50
2024
Q1
$356K Hold
9,945
0.22% 46
2023
Q4
$387K Hold
9,945
0.29% 38
2023
Q3
$263K Buy
9,945
+4,800
+93% +$145K 0.22% 41
2023
Q2
$180K Hold
5,145
0.14% 53
2023
Q1
$171K Hold
5,145
0.13% 63
2022
Q4
$131K Hold
5,145
0.1% 63
2022
Q3
$187K Hold
5,145
0.16% 48
2022
Q2
$246K Hold
5,145
0.2% 39
2022
Q1
$272K Hold
5,145
0.18% 39
2021
Q4
$253K Buy
+5,145
New +$304K 0.16% 49

Other funds holding PRLB

HighMark Wealth Management's PRLB Position: Q2 2026 in Review

HighMark Wealth Management held its Protolabs (PRLB) position steady in Q2 2026 at 345 shares worth $28.1K. The position accounts for 0.01% of the portfolio, ranked #221.

HighMark Wealth Management first reported a position in PRLB in Q4 2021 and has held it in 19 quarters since. The position peaked at $387K in Q4 2023. 278 funds tracked by Wall St. Rank hold PRLB as of Q2 2026.

  • HighMark Wealth Management held 345 shares of Protolabs worth $28.1K as of Q2 2026.
  • HighMark Wealth Management left its Protolabs share count unchanged in Q2 2026.
  • Protolabs made up 0.01% of HighMark Wealth Management's portfolio in Q2 2026, its #221 holding.
  • HighMark Wealth Management first reported a position in Protolabs in Q4 2021 and has held it in 19 quarters since.
  • HighMark Wealth Management's Protolabs position peaked at $387K in Q4 2023.
  • 278 funds tracked by Wall St. Rank held Protolabs as of Q2 2026.

Based on HighMark Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.